# BridgeBio Oncology Therapeutics, Inc.: Form 4, filed Oct 23, 2026

- Company: [BridgeBio Oncology Therapeutics, Inc.](/companies/bbot.md) (CIK 1869105)
- Form: 4
- Filed: 2026-10-23
- Accepted by EDGAR: Oct 23, 2026, 16:15 ET
- Period: 2026-10-21
- Accession: 0001193125-26-430449
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1869105/000119312526430449/xslF345X06/ownership.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1869105/000119312526430449/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1869105/000119312526430449/xslF345X06/ownership.xml

Filed Oct 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-430449. Last ingested by Listed: Nov 14, 2026, 20:40 ET. No prices; not investment advice.
